1.Risk identification and intervention efficacy evaluation of hospital-acquired infections in neurosurgery department based on failure mode and effect analysis
Puyu YANG ; Ye QIU ; Ya YANG ; Zhimin WEI ; Jingru ZHAO ; Weiping ZHU ; Yifeng SHEN ; Yuanping WANG
Shanghai Journal of Preventive Medicine 2026;38(2):159-164
ObjectiveTo establish a regional risk assessment system for hospital-acquired infections in neurosurgery department of general hospital, and to evaluate its prevention and control effectiveness. MethodsFailure mode and effect analysis (FMEA) was used to identify the core risk factors for infections in neurosurgery department. The risk priority number (RPN) of each risk factor was calculated to determine the priority intervention targets. Targeted interventions were developed and continuously refined through the plan-do-check-act (PDCA) cycles. Data from January to June 2023 (control group) and July to December 2023 (intervention group) were collected to compare the differences in environmental hygiene monitoring qualification rate, incidence rate of hospital-acquired infections among inpatients, and detection rate of bacterial antimicrobial resistance. ResultsHigh-risk factors for hospital-acquired infections in neurosurgery department included patient-related risk factors, inadequate implementation of isolation measures for special infections, and poor compliance with surgical site infection (SSI) prevention protocols. After intervention, the environmental hygiene qualification rate significantly increased from 81.55% to 100.00% (χ²=120.49, P<0.001). The overall hospital-acquired infection rate among inpatients decreased from 2.62% to 2.45%, the infection rate of per case declined from 3.12% to 2.84%, and the detection rate of multidrug-resistant organism infections reduced from 43.72% to 36.79%. Additionally, antimicrobial utilization rate decreased from 48.75% to 42.53% (χ²=34.09, P<0.001). ConclusionThe FMEA-based risk assessment system can effectively identify critical infection risks in neurosurgery department, and targeted interventions can significantly improve infection prevention and control performance.
2.Targeting M1/M2 Macrophage Polarization Balance by Traditional Chinese Medicine in Treatment of Bronchial Asthma: A Review
Jie LIU ; Yasheng DENG ; Weiping YIN ; Lei XIONG ; Na WANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(10):308-317
Bronchial asthma (BA) is a common chronic inflammatory airway disease characterized by airway hyperresponsiveness and reversible airflow limitation. Lung macrophages (LMs), as important effector cells of the innate immune system, play an important role in recognizing and engulfing pathogens, clearing harmful particles, and regulating immune responses. LMs can be polarized to M1 (pro-inflammatory) or M2 (anti-inflammatory) in different immune environments and participate in promoting or inhibiting inflammatory response, as well as lung parenchyma injury and repair (airway remodeling), playing a key role in the BA occurrence and development. Regulating the polarization balance of macrophages can not only inhibit the inflammatory response in the airway and reduce airway hyperresponsiveness, but also improve airway remodeling and immune regulation, reduce airway mucus secretion, and alleviate the clinical BA symptoms. Traditional Chinese medicine and its active ingredients, especially polysaccharides and saponins, can regulate the polarization balance of M1/M2 macrophages. Traditional Chinese medicine compounds can balance the secretion of anti-inflammatory and pro-inflammatory factors by staging treatment and targeting the polarization state of M1/M2 macrophages, inhibit inflammatory response in the airway, reduce airway remodeling, and improve the BA symptoms. This paper summarized the research progress on the regulation of M1/M2 macrophage polarization by traditional Chinese medicine and its active ingredients, aiming to provide scientific evidence for the precise targeted therapy of BA.
3.Targeting M1/M2 Macrophage Polarization Balance by Traditional Chinese Medicine in Treatment of Bronchial Asthma: A Review
Jie LIU ; Yasheng DENG ; Weiping YIN ; Lei XIONG ; Na WANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(10):308-317
Bronchial asthma (BA) is a common chronic inflammatory airway disease characterized by airway hyperresponsiveness and reversible airflow limitation. Lung macrophages (LMs), as important effector cells of the innate immune system, play an important role in recognizing and engulfing pathogens, clearing harmful particles, and regulating immune responses. LMs can be polarized to M1 (pro-inflammatory) or M2 (anti-inflammatory) in different immune environments and participate in promoting or inhibiting inflammatory response, as well as lung parenchyma injury and repair (airway remodeling), playing a key role in the BA occurrence and development. Regulating the polarization balance of macrophages can not only inhibit the inflammatory response in the airway and reduce airway hyperresponsiveness, but also improve airway remodeling and immune regulation, reduce airway mucus secretion, and alleviate the clinical BA symptoms. Traditional Chinese medicine and its active ingredients, especially polysaccharides and saponins, can regulate the polarization balance of M1/M2 macrophages. Traditional Chinese medicine compounds can balance the secretion of anti-inflammatory and pro-inflammatory factors by staging treatment and targeting the polarization state of M1/M2 macrophages, inhibit inflammatory response in the airway, reduce airway remodeling, and improve the BA symptoms. This paper summarized the research progress on the regulation of M1/M2 macrophage polarization by traditional Chinese medicine and its active ingredients, aiming to provide scientific evidence for the precise targeted therapy of BA.
4.Distribution characteristics and influencing factors of ultra-long hospitalization in patients with malig-nant tumors
Xiaoyu YANG ; Weiping WANG ; Hongtao WANG ; Yi LIU ; Jiameng ZHOU ; Zehua MA ; Xibei ZHOU ; Bo ZHANG ; Jinpo ZHENG
Modern Hospital 2025;25(8):1223-1226
Objective To analyze the distribution characteristics and influencing factors of ultra-long hospitalization in malignant tumor patients and to explore strategies to reduce the average length of stay and enhance the efficiency of medical re-source utilization.Methods Ultra-long hospitalization was defined as the 99th percentile of hospital stay duration(P99=31 days).Data from patients discharged with malignant tumors in a specialized cancer hospital in 2024 were collected.The distribu-tion characteristics and influencing factors were analyzed using chi-square tests and logistic stepwise regression.Results Among the 36 097 patients with malignant tumors,the average length of stay was 4.95 days,with 375 cases classified as ultra-long hospi-talizations,accounting for 1.04%.These patients were predominantly over 55 years old,with a higher proportion of males.Pa-tients with stage Ⅲ malignant tumors,primary tumors classified as T2~T3,and primary sites in the esophagus,pancreas,and maxillofacial regions had a higher incidence of ultra-long hospitalizations.Significant factors influencing ultra-long hospitalization included treatment modality,complications(OR=20.319),number of discharge diagnoses(OR=6.915),ICU transfers(OR=4.714),unplanned reoperations(OR=4.416),tumor type,extent,and stage.Conclusion Medical institutions are advised to address the influencing factors of ultra-long hospitalizations by optimizing diagnostic and treatment processes,enhan-cing quality control systems,establishing early warning mechanisms,and strengthening information systems.These measures aim to improve the standardization of malignant tumor diagnosis and treatment,ensuring patient safety.
5.Observation of the effects of converting to tacrolimus extended-release capsules in pediatric liver transplant recipients postoperatively
Firuzha FULATI ; Chong DONG ; Chao SUN ; Kai WANG ; Weiping ZHENG ; Xinzhe WEI ; Shengqiao ZHAO ; Ruofan WANG ; Wei GAO ; Hong ZHENG
Chinese Journal of Organ Transplantation 2025;46(9):640-644
Objective:To evaluate the efficacy and safety of once-daily tacrolimus extended-release capsules (OD-TAC) in pediatric liver transplant recipients after conversion from twice-daily tacrolimus (TD-TAC).Methods:A retrospective analysis was performed on pediatric liver transplant recipients at Tianjin First Center Hospital between January 2014 and December 2020 who were converted from TD-TAC to OD-TAC with a follow-up of at least 12 months. After conversion, all patients received OD-TAC monotherapy. The daily dose conversion ratio from TD-TAC to OD-TAC ranged from 2∶1 to 1∶2. Clinical data including demographics, tacrolimus dosage, trough concentrations, liver function, and adverse events were collected. Continuous variables with normal distribution were expressed as Mean±SD and compared using independent-samples t-test or ANOVA; non-normally distributed variables were expressed as median ( Q1, Q3) and compared using Mann-Whitney U or Kruskal-Wallis H tests. Categorical variables were expressed as frequency and percentage, and compared using χ 2 test or Fisher's exact test. P<0.05 was considered statistically significant. Results:A total of 290 children were enrolled, including 140 males (48.3%) and 150 females (51.7%). The median age at transplantation was 7.34 (6.03, 12.34) months, and the median time to conversion was 36 (29, 48) months post-transplant. Tacrolimus daily doses at 3, 6, and 12 months after conversion were slightly higher than before conversion, but without statistical significance (all P>0.05). Trough tacrolimus levels at 6 and 12 months after conversion were 2.34±1.02 μg/L and 2.23±1.07 μg/L, respectively, both lower than pre-conversion (2.77±1.43 μg/L), with statistical significance ( P=0.02 and P<0.01). Serum creatinine levels at 6 and 12 months post-conversion were 2.63±0.63 mmol/L and 2.76±0.68 mmol/L, respectively, both higher than before conversion (2.57±1.90 mmol/L, P<0.05). Triglyceride level at 12 months post-conversion was 0.87±0.25 mmol/L, significantly lower than pre-conversion (1.05±0.55 mmol/L, P<0.05). Two patients developed transient bilirubin elevation at 3 months, and another two developed transient triglyceride elevation at 6 months; all recovered without intervention. No new-onset diabetes was observed during follow-up. Thirteen patients experienced acute rejection. One patient (0.3%) died three years after conversion due to hepatic venous outflow obstruction, while all others survived. Conclusion:In pediatric liver transplant recipients, OD-TAC provides comparable efficacy and safety to TD-TAC.
6.Causal relationship between gut microbiota and rheumatoid arthritis:data analysis in European populations based on GWAS data
Tao WANG ; Shunpu WANG ; Youjiang MIN ; Min WANG ; Le LI ; Chen ZHANG ; Weiping XIAO
Chinese Journal of Tissue Engineering Research 2025;29(35):7663-7668
BACKGROUND:Studies have shown that gut microbiota may affect the progression of rheumatoid arthritis.However,the causal relationship between the two is unknown.Mendelian randomization analysis of the two using published Genome Wide Association Study(GWAS)data can explore the causal relationship between gut microbiota and rheumatoid arthritis,helping to develop targeted microbial therapies and provide methods and strategies for the prevention and treatment of rheumatoid arthritis.OBJECTIVE:To explore the potential causal relationship between gut microbiota and rheumatoid arthritis using two-sample two-way Mendelian randomization method.METHODS:Gut microbiota GWAS data from the MiBio-Gen consortium and rheumatoid arthritis GWAS data from the IEU Open GWAS database(a large gene-phenotype association database developed at the MRC Integrative Epidemiology Unit(IEU)at the University of Bristol,UK)were used.Inverse variance weighting was used as the main analysis method,and MR-Egger regression method,weighted median method,weighted model and simple model method were used as supplements to study the causal relationship between gut microbiota and rheumatoid arthritis.Heterogeneity was assessed using Cochran's Q test,horizontal pleiotropy was assessed using MR-PRESSO and MR-Egger intercept tests,robustness of results was tested using leave-one method,and reverse Mendelian randomization analysis was used to assess the presence or absence of reverse causality.RESULTS AND CONCLUSION:(1)There was a causal relationship between five kinds of enteric bacteria and rheumatoid arthritis.Ruminococcus gauvreauii group(β=0.262,odds ratio[OR]=1.300,P=0.013)and Butyricimonas(β=0.001,OR=1.001,P=0.014)increased the risk of rheumatoid arthritis,while Anaerostipes(β=-0.225,OR=0.798,P=0.025),Lachnospiraceae-UCG010(β=-0.177,OR=0.838,P=0.026)and Oxalobacter(β=-0.171,OR=0.843,P=0.001)reduced the risk of rheumatoid arthritis.Sensitivity analyses showed no significant heterogeneity or horizontal pleiotropy(all P>0.05),and leave-one-out testing confirmed the robustness of the results,while the addition of the remaining four methods other than the inverse variance weighting method further validated the reliability and stability of the results.(2)Reverse Mendelian randomization analysis did not find a causal association between rheumatoid arthritis and the five kinds of enteric bacteria identified by Mendelian randomization analysis.These findings indicate that Ruminococcus gauvreauii group and Butyricimonas may be the risk factors of rheumatoid arthritis,while Anaerostipes,Lachnospiraceae-UCG010 and Oxalobacter may be the protective factors of rheumatoid arthritis.Gut microbiota may play an important role in the pathogenesis of rheumatoid arthritis,and provide new biomarkers for the prevention and treatment of rheumatoid arthritis.In addition,for the field of biomedical research in China,we can learn from international experience and gradually establish and improve a multi-center large-scale genetic database,so as to deeply explore the relationship between gut microbiota and disease risk,and promote the development of precision medicine and personalized treatment in China.
7.Two case reports of pediatric urinary non-Hodgkin lymphoma
Haiyan LIANG ; Hongcheng SONG ; Xingfeng YAO ; Bei WANG ; Ning LI ; Weiping ZHANG ; Ning SUN
Chinese Journal of Urology 2025;46(1):65-66
Pediatric urological non-Hodgkin lymphoma is relatively rare.When a single renal or ureteral tumor with multiple lymph node or bone metastases is present, it is very easy to be misdiagnosed as urinary tumor with metastasis, resulting in unnecessary radical nephrectomy. This paper reports two cases of non-Hodgkin lymphoma presenting with single urinary nodules. Case 1 was diagnosed with a 4.5cm tumor in the right kidney due to fever and fatigue. CT and PET-CT showed multiple bone destruction and lymph node metastasis. Renal biopsy was performed and ALK-positive anaplastic large cell lymphoma was diagnosed. Chemotherapy was effective for 6 months. Case 2 was diagnosed with left hydronephrosis due to intermittent low back pain for 2 weeks. Ultrasound examination revealed ureteral dilation with left hydronephrosis and low echo occupying of the lower ureter. The patient had sudden blurred vision before surgery. MRI examination revealed space occupying in the right optic nerve frame, and PET-CT found multiple bone, lymph nodes and nerve invasion. A lymph node biopsy was performed and Burkitt lymphoma was diagnosed. After 6 months of chemotherapy and radiotherapy, the tumor shrank significantly.
8.Prevalence and Phylogenetic Analysis of Human Parvovirus B19 among Blood Donors in Lanzhou
Kangle WU ; Weirong WANG ; Shulong YANG ; Weiping FENG ; Deng PAN ; Yi GUO ; Zhifeng ZHANG
Journal of Modern Laboratory Medicine 2025;40(2):59-63
Objective To examine the serological and molecular prevalence as well as genotype characteristics of human Parvovirus B19 blood donors in Lanzhou,and to provide evidence for developing a screening strategy to reduce the risk of blood transfusion transmission.Methods A total of 5 722 blood samples collected from Lanzhou blood donors from April 2023 to October 2023 were tested for B19 DNA using real-time quantitative PCR(qRT-PCR).Additionally,383 samples were screened for anti-B19 IgG and anti-B19 IgM using synchronous enzyme-linked immunoassay(ELISA).Viral load and VP1 sequencing were conducted on the B19 DNA-positive samples and the Neighbor-Joining(N-J)method was used to construct an evolutionary tree for the sequenced samples.Results The prevalence of human Parvovirus B19 DNA,IgG antibody and IgM antibody was 0.47%(27/5 722),25.59%(98/383)and 0.26%(1/383),respectively,and the samples positive for B19 DNA,IgG antibody and IgM antibody were 0.26%(1/383).The co-positivity rate for B19 DNA and IgG antibody was 6.27%(24/383),while the positivity rates for B19 DNA or IgG antibody alone were 0.52%(2/383)and 19.06%(73/383),respectively.Viral loads ranged from 4.24 IU/ml to 5.67×102 IU/ml,all below 104 IU/ml.There was no statistical significance in the positive rate of B19 DNA in gender(χ2=0.86,P=0.35),but there was statistical significance in the positive rate of B19 DNA among all age groups(χ2=8.00,P=0.02).The highest positive rate of B19 DNA was 0.65%in the 18~30 age group.There was statistical significance in the positive rate of B19 IgG antibody in gender(χ2=5.03,P=0.02),but there was no statistical significance in the positive rate of B19 IgG antibody among all age groups(χ2=0.51,P=0.77).The highest positive rate of B19 IgG antibody was 29.09%in the age group of 41 to 60.There was no significant difference in the positive rate of B19 IgM antibody in gender(χ2=2.84,P=0.09).The highest positive rate of B19 IgM was 3.85%in the age group of 18~30 years old.Based on the VP1 sequence,the phylogenetic tree revealed that B19 strains in Lanzhou formed a distinct cladistic lineage within genotype 1,predominantly represented by genotype 1b.Conclusion The prevalence of B19 DNA and IgM antibodies among blood donors in the Lanzhou area is low,and so is the viral load.Therefore the risk of transmitting B19 through blood transfusion is relatively small.Since the prevalence of B19 IgG antibody is high,it is suggested to closely monitor the transmission situation in the area,regularly monitor the prevalence of B19 among blood donors,and track the situation of B19 DNA-positive blood donors to recipients to ensure the safety of clinical blood transfusion.
9.Observation of the effects of converting to tacrolimus extended-release capsules in pediatric liver transplant recipients postoperatively
Firuzha FULATI ; Chong DONG ; Chao SUN ; Kai WANG ; Weiping ZHENG ; Xinzhe WEI ; Shengqiao ZHAO ; Ruofan WANG ; Wei GAO ; Hong ZHENG
Chinese Journal of Organ Transplantation 2025;46(9):640-644
Objective:To evaluate the efficacy and safety of once-daily tacrolimus extended-release capsules (OD-TAC) in pediatric liver transplant recipients after conversion from twice-daily tacrolimus (TD-TAC).Methods:A retrospective analysis was performed on pediatric liver transplant recipients at Tianjin First Center Hospital between January 2014 and December 2020 who were converted from TD-TAC to OD-TAC with a follow-up of at least 12 months. After conversion, all patients received OD-TAC monotherapy. The daily dose conversion ratio from TD-TAC to OD-TAC ranged from 2∶1 to 1∶2. Clinical data including demographics, tacrolimus dosage, trough concentrations, liver function, and adverse events were collected. Continuous variables with normal distribution were expressed as Mean±SD and compared using independent-samples t-test or ANOVA; non-normally distributed variables were expressed as median ( Q1, Q3) and compared using Mann-Whitney U or Kruskal-Wallis H tests. Categorical variables were expressed as frequency and percentage, and compared using χ 2 test or Fisher's exact test. P<0.05 was considered statistically significant. Results:A total of 290 children were enrolled, including 140 males (48.3%) and 150 females (51.7%). The median age at transplantation was 7.34 (6.03, 12.34) months, and the median time to conversion was 36 (29, 48) months post-transplant. Tacrolimus daily doses at 3, 6, and 12 months after conversion were slightly higher than before conversion, but without statistical significance (all P>0.05). Trough tacrolimus levels at 6 and 12 months after conversion were 2.34±1.02 μg/L and 2.23±1.07 μg/L, respectively, both lower than pre-conversion (2.77±1.43 μg/L), with statistical significance ( P=0.02 and P<0.01). Serum creatinine levels at 6 and 12 months post-conversion were 2.63±0.63 mmol/L and 2.76±0.68 mmol/L, respectively, both higher than before conversion (2.57±1.90 mmol/L, P<0.05). Triglyceride level at 12 months post-conversion was 0.87±0.25 mmol/L, significantly lower than pre-conversion (1.05±0.55 mmol/L, P<0.05). Two patients developed transient bilirubin elevation at 3 months, and another two developed transient triglyceride elevation at 6 months; all recovered without intervention. No new-onset diabetes was observed during follow-up. Thirteen patients experienced acute rejection. One patient (0.3%) died three years after conversion due to hepatic venous outflow obstruction, while all others survived. Conclusion:In pediatric liver transplant recipients, OD-TAC provides comparable efficacy and safety to TD-TAC.
10.Predictive factors for testicular atrophy in children with testicular torsion following orchiopexy
Chinese Journal of Urology 2025;46(9):704-710
Objective:To explore the predictive factors for testicular atrophy in children with testicular torsion following orchiopexy.Methods:The clinical data of 82 patients with testicular torsion and orchiopexy admitted to Beijing Children’s Hospital Affiliated to Capital Medical University between October 2015 and September 2021 were retrospectively analyzed. The age was 147(110,162)months. Among these patients,62 presented with scrotal pain as the initial symptom,while 20 exhibited atypical symptoms. Regarding referral history,36 cases had no referrals,39 cases had one referral,and 7 cases had two or more referrals. Preoperative testicular ultrasonography revealed homogeneous echotexture in 24 cases and heterogeneous echotexture in 58 cases. Testicular blood flow was normal in 3 cases,reduced in 17 cases,and absent in 62 cases. Testicular torsion was considered at first diagnosis,testicular exploration was performed,and testicular fixation was performed if the testicle was viable. If bilateral testicular ultrasound examination was performed over 3 months after the operation,and the results showed that the difference in volume(TVL)between the affected testicle and the unaffected testicle was >50% or the blood flow in the affected testicle was absent,it was defined as testicular atrophy. If no ultrasound examination was performed over 3 months after the operation,but the ultrasound examination within 3 months after the operation indicated the absence of blood flow in the affected testicle,it was also defined as testicular atrophy. Univariate analysis was used to compare the clinical data between the two groups according to whether there was testicular atrophy or not. Multivariate logistic regression was used to analyze the independent risk factors associated with postoperative testicular atrophy. The predictive value of each factor was analyzed by receiver operating characteristic(ROC)curve.Results:Of the 82 patients,32(39.0%)had testicular atrophy after surgery.Patients presenting with atypical initial symptoms exhibited a significantly higher incidence of testicular atrophy compared to those with scrotal pain[75.0%(15/20)vs. 27.4%(17/62), P<0.001]. Additionally,patients who underwent ≥2 referrals demonstrated a markedly elevated rate of testicular atrophy relative to those with 0 or 1 referral[100.0%(7/7)vs. 33.3%(12/36)vs. 33.3%(13/39), P=0.002]. The incidence of testicular atrophy varied significantly depending on the level of the hospital where the patient was initially diagnosed:primary hospitals(100.0%,5/5),secondary general hospitals(50.0%,6/12),tertiary general hospitals(34.8%,8/23),and tertiary women and children’s hospitals(31.0%,13/42),with statistical significance( P=0.020). Furthermore,patients with uneven testicular echogenicity preoperatively were more likely to develop testicular atrophy than those with uniform echogenicity[55.2%(32/58)vs. 0, P<0.001]. Preoperative testicular ultrasonography revealed a significant difference in the rate of testicular atrophy among patients with absent blood flow,reduced blood flow,and normal blood flow[50.0%(31/62)vs. 5.9%(1/17)vs. 0, P=0.001]. Patients experiencing testicular atrophy had a longer preoperative preparation time compared to those without atrophy[median 4.0(3.4,5.1)h vs. 3.5(3.0,4.2)h, P=0.017]. Moreover,the duration of symptoms was significantly longer in patients with testicular atrophy than in those without[25.5(13.0,49.5)h vs. 8.0(6.3,11.8)h, P<0.001]. Finally,contralateral testicular fixation was associated with a higher incidence of testicular atrophy,with a statistically significant difference observed between groups[50.0%(23/46)vs. 25.0%(9/36), P=0.038]. Multivariate logistic regression analysis revealed that preoperative testicular ultrasound blood flow loss( OR = 1.22, P = 0.034),uneven testicular ultrasound echo( OR = 1.33, P = 0.007),and not performing contralateral testicular fixation( OR = 0.77, P = 0.003)were independent predictors of postoperative testicular atrophy. The area under the curve(AUC)for predicting postoperative testicular atrophy was 0.68,0.74,and 0.63,respectively. Conclusions:Lack of preoperative testicular ultrasound blood flow and uneven preoperative testicular ultrasound echo have good predictive value for testicular atrophy after testicular torsion testicular fixation in children,and the best predictor is uneven preoperative testicular ultrasound echo. The correlation between contralateral testicular fixation and postoperative testicular atrophy needs further study.

Result Analysis
Print
Save
E-mail